{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:53:18Z","timestamp":1761742398557},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":9132,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1111\/1523-1747.ep12875030","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T01:47:34Z","timestamp":1089856054000},"page":"S132-S137","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Recombinant Interferon-Gamma (rIFN-gamma) in Dermatology"],"prefix":"10.1016","volume":"95","author":[{"given":"Gustav","family":"Mahrle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Joachim","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12875030_bb0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.149.3681.310","article-title":"Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin","volume":"149","author":"Wheelock","year":"1965","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12875030_bb0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/298859a0","article-title":"Structure of the human immune interferon gene","volume":"298","author":"Gray","year":"1982","journal-title":"Nature"},{"key":"10.1111\/1523-1747.ep12875030_bb0020","first-page":"3","article-title":"Interferons and their induction","author":"Carlin","year":"1988"},{"key":"10.1111\/1523-1747.ep12875030_bb0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0140-6736(89)92455-0","article-title":"Interferons","author":"Balkwill","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12875030_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00199301","article-title":"A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumours","volume":"25","author":"Wagstaff","year":"1987","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/1523-1747.ep12875030_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1083\/jcb.104.3.689","article-title":"Inhibition of endothelial cell proliferation by gamma-interferon","volume":"104","author":"Friesel","year":"1987","journal-title":"J Cell Biol"},{"key":"10.1111\/1523-1747.ep12875030_bb0040","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/archderm.1987.01660360061013","article-title":"Use of recombinant interferon gamma administered intramuscularly for the treatment of psoriasis","volume":"123","author":"Morhenn","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2133.1989.tb01795.x","article-title":"Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions","volume":"121","author":"Nickoloff","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(89)70078-5","article-title":"Interferons in dermatology","volume":"20","author":"Stadler","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/eji.1830150204","article-title":"Recombinant interferongamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens","volume":"15","author":"Carrel","year":"1985","journal-title":"Eur J Immunol"},{"key":"10.1111\/1523-1747.ep12875030_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/01913128609015559","article-title":"Ultrastructural effects of recombinant gamma interferon on cultured human keratinocytes","volume":"10","author":"Nickoloff","year":"1986","journal-title":"Ultrastruct Pathol"},{"key":"10.1111\/1523-1747.ep12875030_bb0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00431060","article-title":"Induction of mRNA for HLA-DR beta in human keratinocytes cocultured with interferon-gamma","volume":"281","author":"Nilsson","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/1523-1747.ep12875030_bb0070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00418173","article-title":"Effect of interferon (rIFN-alpha 2, rIFN-gamma) on DNA-synthesis and HLA-DR expression in psoriasis","volume":"278","author":"Schulze","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/1523-1747.ep12875030_bb0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/1523-1747.ep12696816","article-title":"Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes","volume":"92","author":"Symington","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0080","first-page":"576","article-title":"The absence of interferon antibody fermation in patients receiving recombinant human interferon-gamma","volume":"6","author":"Jaffe","year":"1987","journal-title":"J Biol Resp Modif"},{"key":"10.1111\/1523-1747.ep12875030_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/1523-1747.ep12284016","article-title":"The effect of in vivo interferon-gamma on the distribution of LFA-1 and ICAM-1 in normal human skin","volume":"93","author":"Barker","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0090","first-page":"550","article-title":"Presence of ICAM-1 on melanoma cells in vitro and enhancement of its expression by interferons","volume":"93","author":"Garbe","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0190-9622(89)70083-9","article-title":"T-lymphocytes and monocytes bind to keratinocytes in frozen sections of biopsy specimens of normal skin treated with gamma interferon","volume":"20","author":"Nickoloff","year":"1989","journal-title":"J Amer Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0100","first-page":"569","article-title":"Interferon-gamma. A potent inducer of local inflammation","volume":"93","author":"Pinocy","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0105","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI112956","article-title":"Persistence of a reduced-collagen-producing phenotype us cultured scleroderma fibroblasts after short-term exposure to interferons","volume":"79","author":"Duncan","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/1523-1747.ep12875030_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/1523-1747.ep12277336","article-title":"The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model","volume":"93","author":"Granstein","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0115","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(89)92686-X","article-title":"Effects of intradermal gamma-interferon in cutaneous leishmaniasis","author":"Harms","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12875030_bb0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM198607033150102","article-title":"Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy","volume":"315","author":"Nathan","year":"1986","journal-title":"New Engl J Med"},{"key":"10.1111\/1523-1747.ep12875030_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198807213190305","article-title":"Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon-gamma","volume":"319","author":"Ezekowitz","year":"1988","journal-title":"New Engl J Med"},{"key":"10.1111\/1523-1747.ep12875030_bb0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/jir.1988.8.367","article-title":"Effect of interferon-gamma treatment on the course of a burn wound infection","volume":"8","author":"Hershman","year":"1988","journal-title":"J Interf Res"},{"key":"10.1111\/1523-1747.ep12875030_bb0135","first-page":"155A","article-title":"Gamma-interferon induced inhibition of eicosanoid synthesis in human skin","volume":"33","author":"Pandey","year":"1985","journal-title":"Clin Res"},{"key":"10.1111\/1523-1747.ep12875030_bb0140","first-page":"2866","article-title":"Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients","volume":"45","author":"Kurzrock","year":"1985","journal-title":"Cancer Res"},{"key":"10.1111\/1523-1747.ep12875030_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00205575","article-title":"A phase I trial of recombinant gamma interferon in patients with cancer","volume":"20","author":"Foon","year":"1985","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/1523-1747.ep12875030_bb0150","first-page":"32","article-title":"Phase I-II trial of recombinant interferon gamma by 2 or 24hr infusion in 30 melanoma patients","volume":"4","author":"Trautmann","year":"1985","journal-title":"Proc Amer Soc Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875030_bb0155","first-page":"843","article-title":"Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma","volume":"71","author":"Creagan","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/1523-1747.ep12875030_bb0160","first-page":"335","article-title":"Interferon-gamma treatment of metastasized malignant melanoma","volume":"7","author":"Haase","year":"1987","journal-title":"Anticancer Res"},{"key":"10.1111\/1523-1747.ep12875030_bb0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0190-9622(89)80151-3","article-title":"Adjuvant therapy of high-risk malignant melanoma patients with gamma-interferon","volume":"20","author":"Landthaler","year":"1989","journal-title":"J Amer Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00390040","article-title":"Comparison of the effect of three different treatment regimens of recombinant interferons (rIFN-alpha, rIFN-gamma, and rIFN-alpha + cimetidine) in disseminated malignant melanoma","volume":"113","author":"Steiner","year":"1987","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875030_bb0175","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/1097-0142(19860415)57:8+<1675::AID-CNCR2820571307>3.0.CO;2-I","article-title":"Interferons in the treatment of malignant melanoma. A review of recent trials","volume":"57","author":"Legha","year":"1986","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875030_bb0180","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198812223192527","article-title":"Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma","volume":"319","author":"Rosenberg","year":"1988","journal-title":"New Engl J Med"},{"key":"10.1111\/1523-1747.ep12875030_bb0185","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/1097-0142(19881215)62:12<2472::AID-CNCR2820621203>3.0.CO;2-G","article-title":"A phase I-II trial of the combination of recombinant A interferon and recombinant human interferon gamma in patients with metastatic malignant melanoma","volume":"62","author":"Creagan","year":"1988","journal-title":"Cancer"},{"key":"10.1111\/1523-1747.ep12875030_bb0190","first-page":"551","article-title":"Beta- and gamma-interferon in malignant melanoma","volume":"93","author":"Garbe","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0195","first-page":"566","article-title":"Beta- and gamma-interferon therapy of malignant melanoma","volume":"93","author":"M\u00fcller","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0200","first-page":"105","article-title":"Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma","volume":"12","author":"Taguchi","year":"1988","journal-title":"Cancer Detect Prevent"},{"key":"10.1111\/1523-1747.ep12875030_bb0205","first-page":"163","article-title":"Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon","volume":"9","author":"Ganser","year":"1986","journal-title":"Onkologie"},{"key":"10.1111\/1523-1747.ep12875030_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1200\/JCO.1986.4.2.137","article-title":"Phase I trial of recombinant interferon gamma in cancer patients","volume":"4","author":"Vadhan-Raj","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875030_bb0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0190-9622(86)70192-8","article-title":"Treatment of basal cell carcinoma with intralesional interferon","volume":"15","author":"Greenway","year":"1986","journal-title":"J Amer Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0220","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1200\/JCO.1986.4.7.1101","article-title":"Phase I study of multiple dose intramuscularly administered recombinant gamma interferon","volume":"4","author":"Kurzrock","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875030_bb0225","first-page":"545","article-title":"Treatment of cutaneous T cell lymphomas with interferon and monoclonal antibody T101","volume":"93","author":"Bunn","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0230","first-page":"556","article-title":"Clinical study of Sun 4800 (recombinant interferon gamma) on skin cancer","volume":"93","author":"Ishihara","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0235","first-page":"485","article-title":"Phase I trial of intramuscular recombinant human gamma interferon of refractory genital warts","volume":"86","author":"Kirby","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0240","first-page":"1280","article-title":"Behandlung von Condylomata acuminata mit systemisch appliziertem rekombinanten Interferon-gamma","volume":"62","author":"Fierlbeck","year":"1987","journal-title":"Z Hautkr"},{"key":"10.1111\/1523-1747.ep12875030_bb0245","first-page":"242","article-title":"Low doses of systemically administered recombinant interferon gamma effective in the treatment of genital warts","volume":"90","author":"Gross","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0250","first-page":"560","article-title":"Treatment of condylomata with recombinant interferon gamma","volume":"93","author":"Kowalzick","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0255","first-page":"586","article-title":"Systemic recombinant interferon-gamma (rIFN-gamma) for the treatment of condylomata acuminata","volume":"93","author":"Ch","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-2478(85)90067-7","article-title":"Decreased natural killer cell activity after prolonged administration of interferon in cancer patients","volume":"10","author":"Cuellar","year":"1985","journal-title":"Immun Let"},{"key":"10.1111\/1523-1747.ep12875030_bb0265","first-page":"553","article-title":"Efficacy of interferons on bowenoid papulosis and other precancerous lesions","volume":"93","author":"Gross","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0190-9622(89)80041-6","article-title":"Interferon-gamma as adjuvant therapy for resistant warts","volume":"21","author":"Shiohara","year":"1989","journal-title":"J Amer Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0275","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-108-4-643_2","article-title":"Herpes zoster, postherpetic neuralgia, and interferon-gamma","volume":"108","author":"Usuki","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1111\/1523-1747.ep12875030_bb0280","first-page":"554","article-title":"Gamma interferon therapy of psoriasis","volume":"90","author":"DiGiovanna","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12875030_bb0285","first-page":"270","article-title":"Indikationen f\u00fcr Gamma-Interferon in der Dermatologie","volume":"39","author":"Schulze","year":"1989","journal-title":"Hautarzt"},{"key":"10.1111\/1523-1747.ep12875030_bb0290","first-page":"695","article-title":"Rekombinantes Interferon-gamma bei Psoriasis arthropathica, progressiv systemischer Sklerodermie und Morbus Behcet","volume":"83","author":"Fierlbeck","year":"1988","journal-title":"Med Klin"},{"key":"10.1111\/1523-1747.ep12875030_bb0295","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.294.6581.1185","article-title":"Atopic manifestation in the acquired immune deficiency syndrome: response to recombinant interferon gamma","volume":"294","author":"Parkin","year":"1987","journal-title":"Br Med J"},{"key":"10.1111\/1523-1747.ep12875030_bb0300","first-page":"127","article-title":"In vitro generation of IFN-gamma in relationship to in vivo concentration of IgE and IgG subelasses and Fc RL\/CD23 positive circulating lymphocytes in patients with severe atopic dermatitis (AD)","volume":"144","author":"Wehrmann","year":"1989","journal-title":"Acta Dermato-Venereol"},{"key":"10.1111\/1523-1747.ep12875030_bb0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.1986.4.2.234","article-title":"Clinical toxicity of interferons in cancer patients: A review","volume":"4","author":"Queseda","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1111\/1523-1747.ep12875030_bb0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI113861","article-title":"Interferons mudulate the expression of hormone receptors on the surface of murine melanoma cells","volume":"83","author":"Kameyama","year":"1989","journal-title":"J Clin Invest"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9091206Q?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9091206Q?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T16:28:33Z","timestamp":1549384113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X9091206Q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["S0022202X9091206Q"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12875030","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}